Concepts (171)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anthracyclines | 8 | 2024 | 284 | 3.030 |
Why?
|
Antibiotics, Antineoplastic | 7 | 2024 | 677 | 1.530 |
Why?
|
Heart Diseases | 6 | 2023 | 2785 | 1.490 |
Why?
|
Doxorubicin | 9 | 2024 | 2215 | 1.340 |
Why?
|
Fluorouracil | 4 | 2021 | 1637 | 1.180 |
Why?
|
Myocytes, Cardiac | 6 | 2023 | 1666 | 0.890 |
Why?
|
Myocarditis | 4 | 2022 | 770 | 0.780 |
Why?
|
Neoplasms | 11 | 2024 | 22083 | 0.770 |
Why?
|
Khellin | 2 | 2018 | 5 | 0.740 |
Why?
|
Cardiomyopathies | 7 | 2024 | 1957 | 0.730 |
Why?
|
Toxicity Tests | 1 | 2021 | 114 | 0.730 |
Why?
|
Nucleosides | 1 | 2019 | 131 | 0.640 |
Why?
|
Citric Acid Cycle | 1 | 2019 | 230 | 0.610 |
Why?
|
Cardiovascular Diseases | 10 | 2022 | 15476 | 0.560 |
Why?
|
Cardiotonic Agents | 2 | 2018 | 539 | 0.510 |
Why?
|
Antineoplastic Agents | 6 | 2022 | 13616 | 0.500 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2023 | 1313 | 0.450 |
Why?
|
Heart | 4 | 2022 | 4391 | 0.410 |
Why?
|
Immunotherapy | 2 | 2018 | 4649 | 0.410 |
Why?
|
Zebrafish | 5 | 2020 | 3002 | 0.390 |
Why?
|
Salaries and Fringe Benefits | 2 | 2021 | 257 | 0.310 |
Why?
|
Heart Failure | 6 | 2023 | 11653 | 0.290 |
Why?
|
Cardiovascular Agents | 2 | 2023 | 840 | 0.270 |
Why?
|
Disease Models, Animal | 4 | 2024 | 18216 | 0.240 |
Why?
|
Risk Assessment | 4 | 2024 | 23953 | 0.230 |
Why?
|
Hemopexin | 1 | 2022 | 32 | 0.210 |
Why?
|
Antibodies, Monoclonal | 1 | 2018 | 9176 | 0.190 |
Why?
|
Heme | 1 | 2022 | 313 | 0.170 |
Why?
|
Metabolic Networks and Pathways | 2 | 2018 | 787 | 0.170 |
Why?
|
American Heart Association | 2 | 2022 | 1045 | 0.170 |
Why?
|
Humans | 39 | 2024 | 760437 | 0.170 |
Why?
|
Heme Oxygenase-1 | 1 | 2022 | 365 | 0.170 |
Why?
|
Cardiac Imaging Techniques | 1 | 2021 | 267 | 0.160 |
Why?
|
Death, Sudden | 1 | 2021 | 302 | 0.160 |
Why?
|
Myocardial Bridging | 1 | 2018 | 10 | 0.160 |
Why?
|
Antimetabolites, Antineoplastic | 2 | 2019 | 643 | 0.160 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11729 | 0.150 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2019 | 266 | 0.150 |
Why?
|
Incidence | 3 | 2023 | 21322 | 0.150 |
Why?
|
Coronary Vasospasm | 1 | 2018 | 81 | 0.150 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2022 | 515 | 0.150 |
Why?
|
Xenobiotics | 1 | 2018 | 70 | 0.150 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2024 | 1766 | 0.140 |
Why?
|
Nitroglycerin | 1 | 2018 | 329 | 0.140 |
Why?
|
Medical Oncology | 2 | 2022 | 2318 | 0.140 |
Why?
|
Fibrosis | 1 | 2024 | 2048 | 0.140 |
Why?
|
Autophagy | 2 | 2023 | 1319 | 0.140 |
Why?
|
Ventricular Function, Left | 4 | 2024 | 3876 | 0.130 |
Why?
|
Cardiology | 2 | 2019 | 1668 | 0.130 |
Why?
|
Reimbursement Mechanisms | 1 | 2021 | 664 | 0.130 |
Why?
|
Structure-Activity Relationship | 2 | 2020 | 3075 | 0.130 |
Why?
|
Interferon-gamma | 1 | 2024 | 3157 | 0.130 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2019 | 1540 | 0.130 |
Why?
|
Animals | 14 | 2024 | 168253 | 0.120 |
Why?
|
Malate Dehydrogenase | 1 | 2014 | 40 | 0.120 |
Why?
|
Sex Factors | 3 | 2023 | 10538 | 0.120 |
Why?
|
Troponin | 1 | 2018 | 501 | 0.120 |
Why?
|
Lymphoma | 1 | 2023 | 1901 | 0.110 |
Why?
|
Physicians, Women | 1 | 2019 | 507 | 0.110 |
Why?
|
Zebrafish Proteins | 1 | 2020 | 1012 | 0.110 |
Why?
|
Anemia, Sickle Cell | 1 | 2022 | 1063 | 0.110 |
Why?
|
Retrospective Studies | 7 | 2023 | 80430 | 0.100 |
Why?
|
Stroke Volume | 3 | 2023 | 5487 | 0.100 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2018 | 1240 | 0.100 |
Why?
|
Arrhythmias, Cardiac | 2 | 2022 | 2248 | 0.100 |
Why?
|
Case-Control Studies | 2 | 2020 | 22097 | 0.100 |
Why?
|
Hypotension | 1 | 2018 | 879 | 0.100 |
Why?
|
Proteomics | 2 | 2018 | 3818 | 0.100 |
Why?
|
Breast Neoplasms | 1 | 2019 | 20985 | 0.100 |
Why?
|
Metabolomics | 2 | 2019 | 1653 | 0.100 |
Why?
|
Models, Animal | 1 | 2018 | 2111 | 0.090 |
Why?
|
Mice | 8 | 2024 | 81402 | 0.090 |
Why?
|
Electrocardiography | 2 | 2021 | 6380 | 0.090 |
Why?
|
Disease Management | 1 | 2021 | 2501 | 0.090 |
Why?
|
Primary Prevention | 1 | 2018 | 1186 | 0.090 |
Why?
|
Cells, Cultured | 3 | 2024 | 18955 | 0.090 |
Why?
|
Risk Factors | 4 | 2023 | 74055 | 0.090 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2018 | 1715 | 0.080 |
Why?
|
Medicare | 3 | 2022 | 6732 | 0.080 |
Why?
|
Prognosis | 3 | 2019 | 29551 | 0.080 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2018 | 2531 | 0.080 |
Why?
|
Blood Vessels | 1 | 2014 | 1113 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2020 | 1925 | 0.080 |
Why?
|
Blood | 1 | 2010 | 584 | 0.070 |
Why?
|
Female | 14 | 2024 | 391875 | 0.070 |
Why?
|
Apoptosis | 3 | 2020 | 9468 | 0.070 |
Why?
|
Prospective Studies | 3 | 2021 | 54339 | 0.070 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2018 | 2117 | 0.070 |
Why?
|
Cardiovascular System | 1 | 2014 | 835 | 0.070 |
Why?
|
Aged | 8 | 2023 | 168840 | 0.070 |
Why?
|
Heart Injuries | 1 | 2008 | 205 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 3243 | 0.070 |
Why?
|
Mice, Inbred C57BL | 3 | 2024 | 22121 | 0.070 |
Why?
|
Biomedical Technology | 1 | 2008 | 210 | 0.070 |
Why?
|
Cell Line | 2 | 2018 | 15598 | 0.060 |
Why?
|
Follow-Up Studies | 2 | 2023 | 39078 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2022 | 7849 | 0.060 |
Why?
|
Chemokine CXCL9 | 1 | 2024 | 135 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7380 | 0.060 |
Why?
|
Male | 12 | 2024 | 360035 | 0.060 |
Why?
|
Cell Degranulation | 1 | 2024 | 276 | 0.050 |
Why?
|
Receptors, CXCR3 | 1 | 2024 | 238 | 0.050 |
Why?
|
Chemokine CXCL10 | 1 | 2024 | 316 | 0.050 |
Why?
|
Granzymes | 1 | 2024 | 277 | 0.050 |
Why?
|
Middle Aged | 7 | 2023 | 220382 | 0.050 |
Why?
|
Bromocriptine | 1 | 2022 | 93 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3080 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3200 | 0.050 |
Why?
|
Systole | 1 | 2024 | 937 | 0.050 |
Why?
|
Peripartum Period | 1 | 2022 | 137 | 0.050 |
Why?
|
Mitochondria | 1 | 2014 | 3624 | 0.050 |
Why?
|
United States | 4 | 2022 | 72202 | 0.050 |
Why?
|
Adult | 5 | 2023 | 220781 | 0.050 |
Why?
|
Cohort Studies | 1 | 2023 | 41366 | 0.050 |
Why?
|
Ritonavir | 1 | 2022 | 329 | 0.050 |
Why?
|
Heart Block | 1 | 2022 | 392 | 0.040 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2023 | 316 | 0.040 |
Why?
|
Prolactin | 1 | 2022 | 625 | 0.040 |
Why?
|
Pancreatic Neoplasms | 1 | 2018 | 5359 | 0.040 |
Why?
|
Myocardium | 2 | 2024 | 4700 | 0.040 |
Why?
|
Dogs | 1 | 2024 | 3839 | 0.040 |
Why?
|
Time Factors | 2 | 2019 | 39947 | 0.040 |
Why?
|
Energy Metabolism | 1 | 2010 | 2875 | 0.040 |
Why?
|
bcl-2-Associated X Protein | 1 | 2020 | 282 | 0.040 |
Why?
|
Niacinamide | 1 | 2020 | 413 | 0.040 |
Why?
|
Mass Spectrometry | 2 | 2018 | 2189 | 0.040 |
Why?
|
Drug Interactions | 1 | 2022 | 1415 | 0.040 |
Why?
|
Cell Adhesion | 1 | 2024 | 3088 | 0.040 |
Why?
|
Lysosomes | 1 | 2023 | 919 | 0.040 |
Why?
|
Kinetics | 2 | 2018 | 6377 | 0.030 |
Why?
|
Fasting | 1 | 2023 | 1600 | 0.030 |
Why?
|
Proteins | 1 | 2011 | 6033 | 0.030 |
Why?
|
Mutagenesis | 1 | 2020 | 1233 | 0.030 |
Why?
|
Necrosis | 1 | 2020 | 1604 | 0.030 |
Why?
|
Drug Substitution | 1 | 2018 | 288 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2019 | 64591 | 0.030 |
Why?
|
Carbanilides | 1 | 2014 | 18 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2010 | 4923 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2020 | 1561 | 0.030 |
Why?
|
Sex Distribution | 1 | 2019 | 2281 | 0.030 |
Why?
|
Small Molecule Libraries | 1 | 2020 | 732 | 0.030 |
Why?
|
Fibroblasts | 1 | 2024 | 4106 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 2018 | 973 | 0.030 |
Why?
|
Myocardial Infarction | 2 | 2018 | 11453 | 0.030 |
Why?
|
Exercise | 1 | 2010 | 5874 | 0.030 |
Why?
|
Lymphocyte Activation | 1 | 2024 | 5491 | 0.030 |
Why?
|
Pandemics | 2 | 2022 | 8623 | 0.020 |
Why?
|
Renal Dialysis | 1 | 2020 | 1795 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 2014 | 0.020 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2010 | 67 | 0.020 |
Why?
|
Muscle Contraction | 1 | 2014 | 1197 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 26063 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2022 | 9533 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2023 | 12320 | 0.020 |
Why?
|
Isotopes | 1 | 2008 | 125 | 0.020 |
Why?
|
Coronary Sinus | 1 | 2008 | 84 | 0.020 |
Why?
|
Computational Biology | 1 | 2018 | 3510 | 0.020 |
Why?
|
Coronary Angiography | 1 | 2018 | 4468 | 0.020 |
Why?
|
Registries | 1 | 2022 | 8216 | 0.020 |
Why?
|
Medicaid | 1 | 2019 | 2810 | 0.020 |
Why?
|
Databases, Factual | 1 | 2021 | 7948 | 0.020 |
Why?
|
Reference Standards | 1 | 2008 | 1004 | 0.020 |
Why?
|
Models, Cardiovascular | 1 | 2008 | 985 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16585 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2010 | 1880 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2011 | 20078 | 0.010 |
Why?
|
Massachusetts | 1 | 2015 | 8826 | 0.010 |
Why?
|
Pregnancy | 1 | 2022 | 29831 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2014 | 16945 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2011 | 15257 | 0.010 |
Why?
|
Rats | 1 | 2008 | 23712 | 0.010 |
Why?
|
Concepts
(171)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(67)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_